News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: cjgaddy post# 206336

Friday, 02/13/2015 11:30:02 AM

Friday, February 13, 2015 11:30:02 AM

Post# of 347009
CJ... very impressive to see Kenneth Dart maintaining a strong interest in accumulating shares of Peregrine Pharmaceuticals. Very nice indeed.

thanks for the update!

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!